Association of germline microRNA SNPs in pre-miRNA flanking region and breast cancer risk and survival: The Carolina Breast Cancer Study

Cancer Causes and Control

Volumn 24, Issue 6, 2013, Pages 1099-1109

  Bensen, Jeannette T ^a,b   Tse, Chiu Kit ^a   Nyante, Sarah J ^c   Barnholtz Sloan, Jill S ^d   Cole, Stephen R ^a   Millikan, Robert C ^a,b  

^a University of North Carolina at Chapel Hill   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Breast cancer; Germline; MicroRNA; Risk; Single nucleotide polymorphism; Survival

Indexed keywords

MICRORNA; MICRORNA 185; UNCLASSIFIED DRUG;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BREAST CANCER; CANCER MORTALITY; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DNA FLANKING REGION; FEMALE; GENOTYPE; GERM LINE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RACE DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GERM-LINE MUTATION; HUMANS; MICRORNAS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84892779985     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-013-0187-z     Document Type: Article

References (62)

1. Bentwich I, Avniel A, Karov Y et al (2005) Identification of hundreds of conserved and nonconserved human microRNAs. Nat Genet 37:766-770. doi:10.1038/ng1590
2. Schanen BC, Li X (2011) Transcriptional regulation of mammalian miRNA genes. Genomics 97:1-6. doi:10.1016/j.ygeno. 2010.10.005
3. Lee Y, Jeon K, Lee JT et al (2002) MicroRNA maturation: stepwise processing and subcellular localization. EMBO J 21: 4663-4670
4. Heneghan HM, Miller N, Lowery AJ et al (2009) MicroRNAs as novel biomarkers for breast cancer. J Oncol 2009:950201. doi: 10.1155/2010/950201
5. Lewis BP, Burge CB, Bartel DP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120:15-20. doi:10.1016/j.cell. 2004.12.035
6. Lee Y, Kim M, Han J et al (2004) MicroRNA genes are transcribed by RNA polymerase II. EMBO J 23:4051-4060. doi: 10.1038/sj.emboj.7600385
7. Borchert GM, Lanier W, Davidson BL (2006) RNA polymerase III transcribes human microRNAs. Nat Struct Mol Biol 13: 1097-1101. doi:10.1038/nsmb1167
8. Song Gao J, Zhang Y, Li M et al (2010) Atypical transcription of microRNA gene fragments. Nucleic Acids Res 38:2775-2787. doi:10.1093/nar/gkp1242
9. Marson A, Levine SS, Cole MF et al (2008) Connecting microRNA genes to the core transcriptional regulatory circuitry of embryonic stem cells. Cell 134:521-533. doi:10.1016/j.cell. 2008.07.020
10. Baskerville S, Bartel DP (2005) Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes. RNA 11:241-247. doi:10.1261/rna.7240905
11. Duan S, Mi S, Zhang W et al (2009) Comprehensive analysis of the impact of SNPs and CNVs on human microRNAs and their regulatory genes. RNA Biol 6:412-425
12. Sethupathy P, Borel C, Gagnebin M et al (2007) Human microRNA- 155 on chromosome 21 differentially interacts with its polymorphic target in the AGTR1 30 untranslated region: a mechanism for functional single-nucleotide polymorphisms related to phenotypes. Am J Hum Genet 81:405-413. doi:10.1086/519979
13. Mishra PJ, Humeniuk R, Mishra PJ et al (2007) A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistance. Proc Natl Acad Sci USA 104:13513-13518. doi:10.1073/pnas.0706217104
14. Landi D, Gemignani F, Naccarati A et al (2008) Polymorphisms within micro-RNA-binding sites and risk of sporadic colorectal cancer. Carcinogenesis 29:579-584. doi:10.1093/carcin/bgm304
15. Brendle A, Lei H, Brandt A et al (2008) Polymorphisms in predicted microRNA-binding sites in integrin genes and breast cancer: ITGB4 as prognostic marker. Carcinogenesis 29:1394-1399. doi: 10.1093/carcin/bgn126
16. O'Day E, Lal A (2010) MicroRNAs and their target gene networks in breast cancer. Breast Cancer Res 12:201. doi:10.1186/ bcr2484
17. Yu Z, Baserga R, Chen L et al (2010) MicroRNA, cell cycle, and human breast cancer. Am J Pathol 176:1058-1064. doi:10.2353/ ajpath.2010.090664
18. Hoffman AE, Zheng T, Yi C et al (2009) MicroRNA miR-196a-2 and breast cancer: a genetic and epigenetic association study and functional analysis. Cancer Res 69:5970-5977. doi:10.1158/0008- 5472.CAN-09-0236
19. Hu Z, Liang J, Wang Z et al (2009) Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women. Hum Mutat 30:79-84. doi:10.1002/ humu.20837
20. Kontorovich T, Levy A, Korostishevsky M et al (2010) Single nucleotide polymorphisms in miRNA binding sites and miRNA genes as breast/ovarian cancer risk modifiers in Jewish high-risk women. Int J Cancer 127:589-597. doi:10.1002/ijc.25065
21. Akkiz H, Bayram S, Bekar A et al (2011) A functional polymorphism in pre-microRNA-196a-2 contributes to the susceptibility of hepatocellular carcinoma in a Turkish population: a case-control study. J Viral Hepat 18:e399-e407. doi:10.1111/j.1365-2893. 2010.01414.x
22. Mittal RD, Gangwar R, George GP et al (2011) Investigative role of pre-microRNAs in bladder cancer patients: a case-control study in North India. DNA Cell Biol 30:401-406. doi:10.1089/ dna.2010.1159
23. Okubo M, Tahara T, Shibata T et al (2010) Association between common genetic variants in pre-microRNAs and gastric cancer risk in Japanese population. Helicobacter 15:524-531. doi: 10.1111/j.1523-5378.2010.00806.x
24. Jedlinski DJ, Gabrovska PN, Weinstein SR et al (2011) Single nucleotide polymorphism in hsa-mir-196a-2 and breast cancer risk: a case control study. Twin Res Hum Genet 14:417-421. doi: 10.1375/twin.14.5.417
25. Permuth-Wey J, Thompson RC, Burton Nabors L et al (2011) A functional polymorphism in the pre-miR-146a gene is associated with risk and prognosis in adult glioma. J Neurooncol. doi: 10.1007/s11060-011-0634-1
26. Liang D, Meyer L, Chang DW et al (2010) Genetic variants in MicroRNA biosynthesis pathways and binding sites modify ovarian cancer risk, survival, and treatment response. Cancer Res 70:9765-9776. doi:10.1158/0008-5472.CAN-10- 0130
27. Hu Z, Shu Y, Chen Y et al (2011) Genetic polymorphisms in the precursor MicroRNA flanking region and non-small cell lung cancer survival. Am J Respir Crit Care Med 183:641-648. doi: 10.1164/rccm.201005-0717OC
28. Newman B, Moorman PG, Millikan R et al (1995) The Carolina Breast Cancer Study: integrating population-based epidemiology and molecular biology. Breast Cancer Res Treat 35:51-60
29. Millikan R, Eaton A, Worley K et al (2003) HER2 codon 655 polymorphism and risk of breast cancer in African Americans and whites. Breast Cancer Res Treat 79:355-364
30. Millikan RC, Newman B, Tse CK et al (2008) Epidemiology of basal-like breast cancer. Breast Cancer Res Treat 109:123-139. doi:10.1007/s10549-007-9632- 6
31. Weinberg CR, Sandler DP (1991) Randomized recruitment in case-control studies. Am J Epidemiol 134:421-432
32. Cannell IG, Bushell M (2010) Regulation of Myc by miR-34c: a mechanismto prevent genomic instability? Cell Cycle 9:2726-2730
33. Iorio MV, Ferracin M, Liu CG et al (2005) MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65:7065-7070. doi:10.1158/0008-5472.CAN-05-1783
34. Verghese ET, Hanby AM, Speirs V et al (2008) Small is beautiful: microRNAs and breast cancer-where are we now? J Pathol 215:214-221. doi:10.1002/path.2359
35. Tavazoie SF, Alarcon C, Oskarsson T et al (2008) Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451:147-152. doi:10.1038/nature06487
36. Barnholtz-Sloan JS, Shetty PB, Guan X et al (2010) FGFR2 and other loci identified in genome-wide association studies are associated with breast cancer in African-American and younger women. Carcinogenesis 31:1417-1423. doi:10.1093/carcin/ bgq128
37. Tian C, Hinds DA, Shigeta R et al (2006) A genomewide singlenucleotide- polymorphism panel with high ancestry information for African American admixture mapping. Am J Hum Genet 79: 640-649. doi:10.1086/507954
38. Barnholtz-Sloan JS, McEvoy B, Shriver MD et al (2008) Ancestry estimation and correction for population stratification in molecular epidemiologic association studies. Cancer Epidemiol Biomarkers Prev 17:471-477. doi:10.1158/1055-9965.EPI- 07-0491
39. Lin DY, Zeng D, Millikan R (2005) Maximum likelihood estimation of haplotype effects and haplotype-environment interactions in association studies. Genet Epidemiol 29:299-312. doi: 10.1002/gepi.20098
40. Lin D, Zeng D (2006) Likelihood-based inference on haplotype effects in genetic association studies. J Am Stat Assoc 101: 89-104
41. Hu YJ, Lin DY, Zeng D (2010) A general framework for studying genetic effects and gene-environment interactions with missing data. Biostatistics 11:583-598. doi:10.1093/biostatistics/kxq015
42. O'Brien KM, Cole SR, Tse CK et al (2010) Intrinsic breast tumor subtypes, race, and long-Term survival in the Carolina Breast Cancer Study. Clin Cancer Res 16:6100-6110. doi:10.1158/ 1078-0432.CCR-10-1533
43. Hinske LC, Galante PA, Kuo WP et al (2010) A potential role for intragenic miRNAs on their hosts' interactome. BMC Genom 11:533. doi:10.1186/1471-2164-11-533
44. Takahashi Y, Forrest AR, Maeno E et al (2009) MiR-107 and MiR-185 can induce cell cycle arrest in human non small cell lung cancer cell lines. PLoS ONE 4:e6677. doi:10.1371/journal. pone.0006677
45. Liu H, Cao YD, Ye WX et al (2010) Effect of microRNA-206 on cytoskeleton remodelling by downregulating Cdc42 in MDAMB- 231 cells. Tumori 96:751-755
46. Liu M, Lang N, Chen X et al (2011) miR-185 targets RhoA and Cdc42 expression and inhibits the proliferation potential of human colorectal cells. Cancer Lett 301:151-160. doi:10.1016/ j.canlet.2010.11.009
47. Corcoran C, Friel AM, Duffy MJ et al (2011) Intracellular and extracellular microRNAs in breast cancer. Clin Chem 57:18-32. doi:10.1373/clinchem.2010.150730
48. Buffa FM, Camps C, Winchester L et al (2011) MicroRNAassociated progression pathways and potential therapeutic targets identified by integrated mRNA and microRNA expression profiling in breast cancer. Cancer Res 71:5635-5645. doi:10.1158/ 0008-5472.CAN-11-0489
49. Wu H, Zhu S, Mo YY (2009) Suppression of cell growth and invasion by miR-205 in breast cancer. Cell Res 19:439-448. doi: 10.1038/cr.2009.18
50. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281-297
51. Vogt M, Munding J, Gruner M et al (2011) Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cell carcinomas and soft tissue sarcomas. Virchows Arch 458: 313-322. doi:10.1007/s00428-010-1030-5
52. Tarasov V, Jung P, Verdoodt B et al (2007) Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-Arrest. Cell Cycle 6:1586-1593
53. Chang TC, Wentzel EA, Kent OA et al (2007) Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 26:745-752. doi:10.1016/j.molcel.2007.05. 010
54. Raver-Shapira N, Marciano E, Meiri E et al (2007) Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell 26:731-743. doi:10.1016/j.molcel.2007.05.017
55. He L, He X, Lim LP et al (2007) A microRNA component of the p53 tumour suppressor network. Nature 447:1130-1134. doi: 10.1038/nature05939
56. Bommer GT, Gerin I, Feng Y et al (2007) p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr Biol 17:1298-1307. doi:10.1016/j.cub.2007.06.068
57. Corney DC, Flesken-Nikitin A, Godwin AK et al (2007) MicroRNA- 34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth. Cancer Res 67:8433-8438. doi:10.1158/0008-5472. CAN-07- 1585
58. Hermeking H (2010) The miR-34 family in cancer and apoptosis. Cell Death Differ 17:193-199. doi:10.1038/cdd.2009.56
59. Beviglia L, Matsumoto K, Lin CS et al (1997) Expression of the c-Met/HGF receptor in human breast carcinoma: correlation with tumor progression. Int J Cancer 74:301-309
60. Gastaldi S, Comoglio PM, Trusolino L (2010) The met oncogene and basal-like breast cancer: another culprit to watch out for? Breast Cancer Res 12:208. doi:10.1186/bcr2617
61. Adams BD, Furneaux H, White BA (2007) The micro-ribonucleic acid (miRNA) miR-206 targets the human estrogen receptoralpha (ERalpha) and represses ERalpha messenger RNA and protein expression in breast cancer cell lines. Mol Endocrinol 21:1132-1147. doi:10.1210/me.2007-0022
62. Leivonen SK, Makela R, Ostling P et al (2009) Protein lysate microarray analysis to identify microRNAs regulating estrogen receptor signaling in breast cancer cell lines. Oncogene 28: 3926-3936. doi:10.1038/onc.2009.241